Abilis has developed a Best-in-Class bladder cancer test that can be used over 1 million times/year for persons who now require invasive diagnostic workups.
The test can accurately detect 97% of cancers with a urine specimen sent from a home or doctor's office. Like, a recently popularized colon cancer test which has changed the colon cancer market, Abilis's test seeks to also disrupt the bladder cancer market with its non-invasive test.